keyword
MENU ▼
Read by QxMD icon Read
search

Primary insomnia

keyword
https://www.readbyqxmd.com/read/29332683/insomnia-in-primary-care-a-study-from-india
#1
T S Jaisoorya, Ajit Bhalchandra Dahale, Kumar G Sunil, L Manoj, G R Gokul, K Thennarassu
OBJECTIVES: To study the prevalence and clinical correlates of insomnia among a sample of primary care attendees, in the state of Kerala, India. DESIGN: Cross-sectional survey. SETTING: Primary care. PARTICIPANTS: 7017 adult patients [18-60 years] attending 71 primary health centers selected by cluster random sampling. MEASUREMENTS: Patients were assessed for insomnia using the Insomnia Severity Index...
February 2018: Sleep Health
https://www.readbyqxmd.com/read/29332673/prevalence-and-comorbidity-of-sleep-conditions-in-australian-adults-2016-sleep-health-foundation-national-survey
#2
Sarah L Appleton, Tiffany K Gill, Carol J Lang, Anne W Taylor, R Douglas McEvoy, Nigel P Stocks, David A González-Chica, Robert J Adams
OBJECTIVE: To determine the prevalence of sleep conditions (obstructive sleep apnea [OSA], insomnia symptoms, simple snoring, and restless legs) and their associated burden of chronic conditions in a community sample. DESIGN: Cross-sectional national adult online survey. SETTING: Community-based sample. PARTICIPANTS: Australian adults ≥18 years, N = 1011. MEASUREMENTS: A cross-sectional national online survey assessed diagnosed OSA, OSA symptoms, insomnia symptoms, sleep problems, excessive daytime sleepiness (Epworth Sleepiness Scale ≥11), and physician-diagnosed health conditions (heart disease, diabetes, hypertension, reflux disease, lung disease, depression, anxiety/panic disorder, arthritis)...
February 2018: Sleep Health
https://www.readbyqxmd.com/read/29289374/safety-of-flibanserin-in-women-treated-with-antidepressants-a-randomized-placebo-controlled-study
#3
Anita H Clayton, Harry A Croft, James Yuan, Louise Brown, Robert Kissling
BACKGROUND: Depression is often associated with sexual dysfunction, and pharmacologic treatment for hypoactive sexual desire disorder can be considered in women receiving treatment for depression. AIM: To evaluate the safety of flibanserin in women treated for depression with selective serotonin reuptake inhibitors or serotonin and norepinephrine reuptake inhibitors. METHODS: In this double-blinded, randomized, placebo-controlled trial, women with remitted or mild depression treated with selective serotonin reuptake inhibitors or serotonin and norepinephrine reuptake inhibitors who were not postmenopausal and were experiencing symptoms of hypoactive sexual desire disorder (ie, decreased sexual desire and related distress) received flibanserin 50 mg at bedtime (qhs) for 2 weeks and up-titrated to 100 mg qhs, flibanserin 100 mg qhs for the entire treatment period, or placebo for up to 12 weeks...
January 2018: Journal of Sexual Medicine
https://www.readbyqxmd.com/read/29276014/early-selective-serotonin-reuptake-inhibitors-for-recovery-after-stroke-a-meta-analysis-and-trial-sequential-analysis
#4
Si-Chun Gu, Chang-De Wang
BACKGROUND: Potential benefits and risks of early (≤30 days from stroke onset) selective serotonin reuptake inhibitors (SSRIs) treatment for neurologic functional recovery after stroke are not fully understood. METHODS: We searched PubMed, Embase, and the Cochrane Library to identify randomized controlled trials that assessed SSRI medications during the initial ictus after stroke versus placebo. Primary outcome was decrease in National Institutes of Health Stroke Scale (NIHSS) score...
December 21, 2017: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://www.readbyqxmd.com/read/29244201/sleep-disturbances-in-treatment-seeking-ocd-patients-changes-after-concentrated-exposure-treatment
#5
Håkon Nordahl, Audun Havnen, Bjarne Hansen, Lars-Göran Öst, Gerd Kvale
Research indicates that patients with Obsessive Compulsive Disorder (OCD) frequently suffer from comorbid sleep difficulties, and that these difficulties often are not clinically recognized and diagnosed. There has been limited research investigating if comorbid sleep difficulties impair treatment outcome for OCD and if the sleep difficulties change following OCD-treatment. Thirty-six patients with obsessive compulsive disorder underwent concentrated exposure treatment delivered in a group over four consecutive days and were assessed with measures of OCD, depressive symptoms and sleep disturbance at three different time points (pre, post and 6 months follow-up)...
December 15, 2017: Scandinavian Journal of Psychology
https://www.readbyqxmd.com/read/29241028/a-latent-class-analysis-of-ptsd-symptoms-among-inner-city-primary-care-patients
#6
Akm Fazlur Rahman, Amita Manatunga, Ying Guo, Limin Peng, Megan Warnock, Kerry J Ressler, Tanja Jovanovic
OBJECTIVES: Examine evidence for different subclasses of posttraumatic stress disorder (PTSD) symptoms in a sample of trauma exposed, low-income, predominantly African American men and women. Assess the relationship between PTSD subclasses with major depressive disorder (MDD) and types of trauma experienced. METHOD: Latent class analysis (LCA) using a multivariate normal mixture model on the 17-item PTSD Symptom Scale (PSS) was used to identify latent subclasses of PTSD symptoms (N = 5063)...
December 7, 2017: Journal of Psychiatric Research
https://www.readbyqxmd.com/read/29237080/cardiopulmonary-coupling-spectrogram-as-an-ambulatory-clinical-biomarker-of-sleep-stability-and-quality-in-health-sleep-apnea-and-insomnia
#7
Robert Joseph Thomas, Christopher Wood, Matt Travis Bianchi
Study Objectives: Ambulatory tracking of sleep and sleep pathology is rapidly increasing with the introduction of wearable devices. The objective of this study was to evaluate a wearable device which used novel computational analysis of the electrocardiogram (ECG), collected over multiple nights, as a method to track the dynamics of sleep quality in health and disease. Methods: This study used the electrocardiogram as a primary signal, a wearable device, the M1, and an analysis of cardiopulmonary coupling to estimate sleep quality...
December 9, 2017: Sleep
https://www.readbyqxmd.com/read/29234927/toward-a-unified-integration-approach-uniting-diverse-primary-care-strategies-under-the-primary-care-behavioral-health-pcbh-model
#8
Brian E Sandoval, Jennifer Bell, Parinda Khatri, Patricia J Robinson
Primary care continues to be at the center of health care transformation. The Primary Care Behavioral Health (PCBH) model of service delivery includes patient-centered care delivery strategies that can improve clinical outcomes, cost, and patient and primary care provider satisfaction with services. This article reviews the link between the PCBH model of service delivery and health care services quality improvement, and provides guidance for initiating PCBH model clinical pathways for patients facing depression, chronic pain, alcohol misuse, obesity, insomnia, and social barriers to health...
December 12, 2017: Journal of Clinical Psychology in Medical Settings
https://www.readbyqxmd.com/read/29231433/-transcutaneous-vagus-nerve-stimulation-for-primary-insomnia-and-affective-disorder-a-report-of-35-cases
#9
Man Luo, Xiaoxiao Qu, Shaoyuan Li, Jingjun Zhao, Yufeng Zhao, Yue Jiao, Peijing Rong
OBJECTIVE: To observe and evaluate the clinical efficacy of transcutaneous vagus nerve stimulation (taVNS) at auricular concha for primary insomnia (PI) and affective disorder. METHODS: A total of 35 patients who met the diagnosis standard of PI in Diagnostic and statistical manual of mental disorders (5th edition) were included. The self-developed auricular vagus nerve stimulator (TENS-200A) was applied at auricular concha, 30 min per treatment, twice a day, 5 days a week for consecutive 4 weeks...
March 12, 2017: Zhongguo Zhen Jiu, Chinese Acupuncture & Moxibustion
https://www.readbyqxmd.com/read/29231317/-regulation-action-and-nerve-electrophysiology-mechanism-of-acupuncture-on-arousal-state-in-patients-of-primary-insomnia
#10
Yi Liu, Hui Feng, Wenjuan Liu, Hongjing Mao, Yali Mo, Yan Yin, Zhenghe Yu, Lianlian Xu
OBJECTIVE: To compare the difference between acupuncture and estazolam on arousal state in patients of primary insomnia, and to explore its nerve electrophysiology mechanism. METHODS: Sixty-four patients of primary insomnia were randomized into an acupuncture group (32 cases) and a medication group (32 cases). After 3 patients were excluded, 31 cases in the acupuncture group and 30 cases in the medication group were included. Patients in the acupuncture group were treated with acupuncture at Sishencong (EX-HN 1), Anmian (Extra), Shenmen (HT 7), Sanyinjiao (SP 6), Zhaohai (KI 6), Shenmai (BL 62) as main acupoints, combined with supporting acupoints, once a day, five times per week, continuously for 4 weeks...
January 12, 2017: Zhongguo Zhen Jiu, Chinese Acupuncture & Moxibustion
https://www.readbyqxmd.com/read/29229613/acupuncture-with-or-without-combined-auricular-acupuncture-for-insomnia-a-randomised-waitlist-controlled-trial
#11
Ka-Fai Chung, Wing-Fai Yeung, Branda Yee-Man Yu, Feona Chung-Yin Leung, Shi-Ping Zhang, Zhang-Jin Zhang, Roger Man-Kin Ng, Gar-Chung Yiu
BACKGROUND: Few high-quality, large-scale, controlled trials comparing the effectiveness and safety of acupuncture,auricular acupuncture and combined acupuncture treatment for insomnia are available. OBJECTIVE: To carry out a randomised, assessor-blinded, waitlist-controlled trial to test the superiority of combination treatment. METHODS: After in-person and polysomnography screening, 224 subjects (mean age 53.4 years; 75.4% female) with DSM-5 insomnia disorder, who were free from major psychiatric disorders and with sleep-diary-derived sleep efficiency averaged over 1 week of <85%, were randomised to acupuncture alone, acupuncture plus auricular acupuncture (combination treatment), or a waitlist in a 3:3:1 ratio...
December 11, 2017: Acupuncture in Medicine: Journal of the British Medical Acupuncture Society
https://www.readbyqxmd.com/read/29229208/assessment-and-treatment-at-a-pain-clinic-a-one-year-follow-up-of-patients-with-chronic-pain
#12
Andrea Hållstam, Monika Löfgren, Lina Benson, Christer Svensén, Britt-Marie Stålnacke
BACKGROUND AND AIMS: Pain is one of the most common reasons for patients to seek primary health care. Pain relief is likely to be achieved for patients suffering from acute pain, but for individuals with chronic pain it is more likely that the condition will persist. These patients have the option of being referred to specialised pain clinics. However, the complexity surrounding chronic pain patients is not well studied in these settings. This study aimed to describe patients with chronic pain referred to a pain clinic by using the information submitted during their first visit and one year later and also to identify associations between baseline characteristics and improvements in health-related quality of life in the follow-up...
October 2017: Scandinavian Journal of Pain
https://www.readbyqxmd.com/read/29211967/efficacy-and-safety-of-amphetamine-extended-release-oral-suspension-in-children-with-attention-deficit-hyperactivity-disorder
#13
Ann C Childress, Sharon B Wigal, Matthew N Brams, John M Turnbow, Yulia Pincus, Heidi W Belden, Sally A Berry
OBJECTIVES: To determine the efficacy and safety of amphetamine extended-release oral suspension (AMPH EROS) in the treatment of attention-deficit/hyperactivity disorder (ADHD) in a dose-optimized, randomized, double-blind, parallel-group study. METHODS: Boys and girls aged 6 to 12 years diagnosed with ADHD were enrolled. During a 5-week, open-label, dose-optimization phase, patients began treatment with 2.5 or 5 mg/day of AMPH EROS; doses were titrated until an optimal dose (maximum 20 mg/day) was reached...
December 6, 2017: Journal of Child and Adolescent Psychopharmacology
https://www.readbyqxmd.com/read/29208069/the-delirium-drug-scale-is-associated-to-delirium-incidence-in-the-emergency-department
#14
Patrick Viet-Quoc Nguyen, Lucie Pelletier, Isabelle Payot, Judith Latour
BACKGROUND: The Delirium Drug Scale (DDS) is an evaluation scale developed to assess a patient's drug burden for delirium. The primary goal is to validate the association between the DDS score and the incidence of delirium. METHODS: This study was an observational retrospective cross-sectional chart review study in patients aged 75 years and older. It was carried out in three emergency departments of a tertiary care university health center. Patients were included if a medication list was available...
December 6, 2017: International Psychogeriatrics
https://www.readbyqxmd.com/read/29196479/sleep-treatment-outcome-predictors-stop-pilot-study-a-protocol-for-a-randomised-controlled-trial-examining-predictors-of-change-of-insomnia-symptoms-and-associated-traits-following-cognitive-behavioural-therapy-for-insomnia-in-an-unselected-sample
#15
Dan Denis, Thalia C Eley, Fruhling Rijsdijk, Helena M S Zavos, Robert Keers, Colin A Espie, Annemarie I Luik, Isabella Badini, Sarah Derveeuw, Alvin Romero, John Hodsoll, Alice M Gregory
INTRODUCTION: Cognitive-behavioural therapy for insomnia (CBT-I) leads to insomnia symptom improvements in a substantial proportion of patients. However, not everyone responds well to this treatment, and it is unclear what determines individual differences in response. The broader aim of this work is to examine to what extent response to CBT-I is due to genetic and environmental factors. The purpose of this pilot study is to examine feasibility of a design to test hypotheses focusing on an unselected sample, that is, without selection on insomnia complaints, in order to plan a larger behavioural genetics study where most participants will likely not have an insomnia disorder...
December 1, 2017: BMJ Open
https://www.readbyqxmd.com/read/29194467/sleep-hygiene-education-as-a-treatment-of-insomnia-a-systematic-review-and-meta-analysis
#16
Ka-Fai Chung, Chit-Tat Lee, Wing-Fai Yeung, Man-Sum Chan, Emily Wing-Yue Chung, Wai-Ling Lin
Background: Sleep hygiene education (SHE) is commonly used as a treatment of insomnia in general practice. Whether SHE or cognitive-behavioural therapy for insomnia (CBT-I), a treatment with stronger evidence base, should be provided first remains unclear. Objective: To review the efficacy of SHE for poor sleep or insomnia. Methods: We systematically searched six key electronic databases up until May 2017. Two researchers independently selected relevant publications, extracted data and evaluated methodological quality according to the Cochrane criteria...
November 29, 2017: Family Practice
https://www.readbyqxmd.com/read/29185897/pharmacological-treatment-of-insomnia-symptoms-in-individuals-with-substance-use-disorders-in-spain-a-quasi-experimental-study
#17
L Grau-López, L Grau-López, C Daigre, R F Palma-Álvarez, L Rodriguez-Cintas, E Ros-Cucurull, C Roncero
INTRODUCTION: Pharmacological treatment of insomnia in patients with addictions has been hardly investigated and there are few researches about it in an inpatient detoxification. The aim of this study was to describe the outcomes of the pharmacological treatment of insomnia in SUD patients admitted to a detoxification unit in Spain, with a focus on the primary substance of abuse and co-occurring mental disorders. METHODS: A quasi-experimental study was conducted in 481 addicted in patients, who were admitted for substances detoxification in Vall d´Hebron University Hospital, Barcelona, Spain, from 2010 to 2015...
November 29, 2017: Substance Use & Misuse
https://www.readbyqxmd.com/read/29177129/sleep-and-circadian-rhythm-disorders-in-parkinson-s-disease
#18
Priti Gros, Aleksandar Videnovic
Purpose of review: Sleep disorders are among the most challenging non-motor features of Parkinson's disease (PD) and significantly affect quality of life. Research in this field has gained recent interest among clinicians and scientists and is rapidly evolving. This review is dedicated to sleep and circadian dysfunction associated with PD. Recent findings: Most primary sleep disorders may co-exist with PD; majority of these disorders have unique features when expressed in the PD population...
September 2017: Current Sleep Medicine Reports
https://www.readbyqxmd.com/read/29172680/efficacy-and-safety-of-hld200-delayed-release-and-extended-release-methylphenidate-in-children-with-attention-deficit-hyperactivity-disorder
#19
Steven R Pliszka, Timothy E Wilens, Samantha Bostrom, Valerie K Arnold, Andrea Marraffino, Andrew J Cutler, Frank A López, Norberto J DeSousa, Floyd R Sallee, Bev Incledon, Jeffrey H Newcorn
OBJECTIVE: Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) formulation consisting of uniform, dual-layered microbeads with an inner drug-loaded core. DR/ER-MPH is designed to delay the initial release of drug by 8-10 hours, and thereafter, provide a controlled, extended drug release to target onset of effect upon awakening that lasts into the evening. This phase 3 study evaluated the safety and efficacy of DR/ER-MPH on symptoms and temporal at-home functional impairment in children with attention-deficit/hyperactivity disorder (ADHD)...
August 2017: Journal of Child and Adolescent Psychopharmacology
https://www.readbyqxmd.com/read/29157588/sleep-spindles-may-predict-response-to-cognitive-behavioral-therapy-for-chronic-insomnia
#20
Thien Thanh Dang-Vu, Benjamin Hatch, Ali Salimi, Melodee Mograss, Soufiane Boucetta, Jordan O'Byrne, Marie Brandewinder, Christian Berthomier, Jean-Philippe Gouin
BACKGROUND: While cognitive-behavioral therapy for insomnia constitutes the first-line treatment for chronic insomnia, only few reports have investigated how sleep architecture relates to response to this treatment. In this pilot study, we aimed to determine whether pre-treatment sleep spindle density predicts treatment response to cognitive-behavioral therapy for insomnia. METHODS: Twenty-four participants with chronic primary insomnia participated in a 6-week cognitive-behavioral therapy for insomnia performed in groups of 4-6 participants...
November 2017: Sleep Medicine
keyword
keyword
107132
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"